An open clinical study to evaluate the efficacy of trial drug suganthamalli chooranam for lasunathabitham
Phase 2
- Conditions
- Health Condition 1: null- LasunathabithamHealth Condition 2: J030- Streptococcal tonsillitis
- Registration Number
- CTRI/2018/07/014950
- Lead Sponsor
- K RUBA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patient with appropriate symptoms of throat pain dysphagia hoarseness of voice enlarged tonsils referred pain in the ear malaise mild fever with tonsillitis
Exclusion Criteria
congenital anomalies of pharynx physiological hyperplasia of lymphoid follicles malignancy tonsillitis which have indication for surgery tonsilolith quincy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The therapeutic efficacy of trial drug SUGANTHAMALLI CHOORANAM on LASUNATHABITHAMTimepoint: 14 days
- Secondary Outcome Measures
Name Time Method Evaluation of siddha diagnostic parametersTimepoint: 14 days